Hugh A. Sampson, MD is the Kurt Hirschhorn Professor of Pediatrics at the Icahn School of Medicine at Mount Sinai in New York and the Director of the Jaffe Food Allergy Institute. In November 2015, he began working part-time (40%) as Chief Scientific Officer for DBV Technologies. Dr. Sampson’s research has focused on food allergic disorders, including basic immunologic mechanisms responsible for these disorders and novel therapeutic strategies to treat them. He is the Principal Investigator on the NIAID-supported Consortium for Food Allergy Research. He has published over 450 articles, 80 book chapters and edited 6 books on clinical and basic immunopathogenic aspects of food allergic disorders, and was elected to membership in the Institute of Medicine in 2003 for his research. Dr. Sampson is past chair of the Section on Allergy & Immunology of the American Academy of Pediatrics and the past-president of the American Academy of Allergy, Asthma and Immunology.

Dr. Lynda Schneider is a Professor of Pediatrics at Harvard Medical School and Director of the Allergy Program and the Atopic Dermatitis Center at Boston Children’s Hospital. She is a board-certified allergist/immunologist with over 25 years experience in clinical research and patient care for patients with complex allergic and immunologic diseases. She is an investigator for the NIH sponsored Atopic Dermatitis Research Network. Her current food allergy research interests include new treatments for food allergy, the use of Xolair in oral immunotherapy, and the psychological aspects of food allergy.

Robert A. Wood, MD is Professor of Pediatrics and Chief of Pediatric Allergy and Immunology at the Johns Hopkins University School of Medicine, and Professor of International Health at the Johns Hopkins Bloomberg School of Public Health. After completing his residency and fellowship at Johns Hopkins, he joined the faculty in 1988 and became division chief in 2005. Dr. Wood is recognized internationally as an expert in both food allergy and childhood asthma and is a principal investigator in both the Consortium of Food Allergy Research and the Inner City Asthma Consortium. His current research focuses on novel treatment approaches for both food allergy and asthma, for which he is currently principal investigator for over 20 ongoing studies. He has published over 200 manuscripts and numerous book chapters, as well as four books. He has served on numerous editorial boards as well as the Board of Directors of the American Board of Allergy and Immunology, the American Academy of Allergy Asthma and Immunology, and the American Board of Pediatrics.

Dr. Leung is Professor of Pediatrics at University of Colorado Denver School of Medicine. He attended the University of Chicago where he received his PhD in 1975 and a MD in 1977. He did a pediatric internship and residency at Boston Children's Hospital and was a Fellow in Allergy-Immunology at Boston Children's Hospital between 1979-1981. He subsequently joined the faculty at Harvard Medical School with appointments as Assistant Professor (1983) and Associate Professor (1987) in Pediatrics. Since 1989, Dr. Leung has been Head of Pediatric Allergy-Immunology at National Jewish Health. He is a past member of the Board of Directors of the American Academy of Allergy, Asthma and Immunology (AAAAI) as well as The American Board of Allergy and Immunology (ABAI). Since 1994, he has been Director of the NIH funded, University of Colorado Clinical and Translation Research Center Site at National Jewish Health. Between 1998-2015, he was Editor-in-Chief of The Journal of Allergy and Clinical Immunology, the most highly cited journal in its field. He is the current Executive Editor of The Annals of Allergy, Asthma and Immunology.

Dr. Leung has an H-index of 112 and is the author of more than 600 publications and has received over 30 federally funded grants. In 1983, he received the NIH Young Investigator Research Award for research on allergic responses in atopic dermatitis; Between 1995-2005, he was the recipient of a ten year NIH /NHLBI MERIT Award for his work in Kawasaki Syndrome, and in 1997, he won the E. Mead Johnson Award for Outstanding Research in Pediatrics; In 2003, he received the WAO Scientific Achievement Award; in 2004, he was the recipient of The American Skin Association/SID Psoriasis Achievement Award for his work on the role of infection in inflammatory skin diseases; the Institute for Scientific Information (ISI) named him to their list of World’s Most Highly Cited Authors in Immunology (top 0.5% of cited articles in past 20 years) in 2006; In 2004-present, he was appointed Principal Investigator of a multi-medical center NIH/NIAID Atopic Dermatitis Research Network to study mechanisms underlying bacterial and viral infections in atopic dermatitis. In 2012, he was awarded the AAAAI Distinguished Service Award for his contributions as Editor-in-Chief of The Journal of Allergy and Clinical Immunology. In 2013, he was chosen to deliver the prestigious Robert A. Cooke Lectureship at the AAAAI Annual meeting commemorating its founder and adding to numerous named lectureships that Dr. Leung has presented. In 2015, he also named by US News and World Report as being amongst the top 1% of physicians. In 2015, he was honored with The NJH Kauvar Presidential Award. In 2016, the AAAAI voted to name a 2016 AAAAI Foundation Faculty Development Award in his honor, i.e. “The Dr. Donald Y. M. Leung/JACI & AAAAI Foundation Faculty Development Award. In 2018, he received the AAAAI Distinguished Scientist Award for his work in Atopic Dermatitis.

Katrina (Katie) J Allen, MBBS, BMedSc., FRACP, Ph.D, FAAHMS, Theme Director of Population Health, Group Leader of Gastro and Food Allergy at Murdoch Children’s Research Institute, Royal Children’s Hospital Melbourne, Professor of Paediatrics at the University of Melbourne and Professorial Chair of Food Allergy at the University of Manchester. She is an active pediatric gastroenterologist and allergist undertaking research in the evolving field of food allergy. She has published more than 200 peer-reviewed papers and book chapters. Katie is an inaugural Fellow of the Australian Academy of Health and Medical Science, is on five National Health and Medical Research Council (NHMRC) funded studies which all seek to answer parts of the jigsaw with regards to population health and evolution of the new allergy epidemic including gene-environment. immunologic and epigenetic associations with food allergy including the Healthnuts study -a study of 5300 infants followed over the first 10 years of life. Professor Allen is Director of the NHMRC-funded Australian Centre of Food & Allergy Research which aims to translate research findings into clinical practice and public health policy to ensure the best outcomes for children regarding food allergy. Katie has made significant contributions to food allergen labelling standards and sits on the Allergen Labelling committee of the Food Standards Agency Australia New Zealand. Professor Allen sits on several committees of the World Allergy Organisation, the Amercian Academy of Allergy, Asthma Immunology, is on the Board of the Food Allergy Section of the European Association of Allergy and Clinical Immunology and a member of the US Institute of Medicine of the National Academies of Sciences, Engineering and Medicine Food Allergy Committee.

Dr. Shreffler earned his MD and PhD from New York University School of Medicine. Subsequently, he completed a pediatrics residency and allergy/immunology fellowship at Albert Einstein College of Medicine/Montefiore Medical Center. He was faculty at Mount Sinai from 2003 to 2009 where he rose to Associate Professor before moving to Harvard Medical School and Massachusetts General Hospital in 2009 and is currently the Chief of Pediatric Allergy & Immunology and Director of the Food Allergy Center. Dr. Shreffler is a fellow of the American Academy of Allergy, Asthma & Immunology. He is an active peer reviewer for numerous grant study sections and journals, including the Journal of Allergy and Clinical Immunology, for which served as an editorial board member. He is an NIH-funded investigator focused on food allergy, including peanut allergy, and has been Principal or Co-investigator on a number of clinical trials, as well as maintaining an active laboratory research group in the Center for Immunology and Inflammation at MGH. He has lectured nationally and internationally on food allergy–related topics. Among his literature contributions are approximately 50 peer-reviewed articles as well as a number of abstracts and poster presentations.

Bruce J. Lanser, MD, is an Assistant Professor in the Division of Allergy and Clinical Immunology, Department of Pediatrics, at National Jewish Health and the University of Colorado School of Medicine. He graduated from Marquette University and then the Medical College of Wisconsin in Milwaukee. He went on to train in pediatrics at the University of Texas Southwestern Medical Center and Children’s Medical Center of Dallas, where he also served as a Pediatric Chief Resident. He completed his fellowship in Pediatric Allergy and Immunology at National Jewish Health. Dr. Lanser is a Fellow of the American Academy of Pediatrics. Dr. Lanser’s clinical interests include food allergy and FPIES. His research interests include a variety of food allergy topics including improving diagnosis, baked egg and milk, and immunotherapy. Dr. Lanser is the director of the Pediatric Food Allergy Program at National Jewish Health. He also serves as the associate director of the Pediatric Allergy and Immunology fellowship training program.

Dr Rachid is an Assistant Professor At Harvard Medical School and the Associate Director of Research for the FARE food allergy center of excellence and the Director of Allergen Immunotherapy at Boston Children's Hospital. Her research interests include evaluating the role the role of gut microbiota in food allergy and tolerance, role of Tregs in food tolerance and food immunotherapy.

Nathan Rabinovitch, M.D., M.P.H. is a Professor in the Department of Pediatrics – Allergy and Clinical Immunology at National Jewish Health (NJH) and at the University of Colorado School of Medicine in Denver Colorado. Dr. Rabinovitch received his pre-medicine degree from Yeshiva University in New York, and earned his Doctor of Medicine from McGill University School of Medicine in Montreal, Canada. His pediatric residency was completed at the Albert Einstein College of Medicine in NY followed by fellowship training at National Jewish Health. He received his Master’s of Public Health from the University of Colorado School of Medicine. Dr. Rabinovitch is certified by the American Board of Allergy and Immunology and is a member of the American Academy of Allergy Asthma and Immunology and the American Thoracic Society. He has been honored with awards and grants from the Colorado Tobacco Research Program EPA and NIH and has been a member of several national and regional committees including the Colorado Regional Air Quality Council, the National Urban Air Toxics Research Center and the California Tobacco Related Disease Research Program. His is a current reviewer for a number of academic journals including JAMA and the American Journal of Respiratory and Critical Care Medicine and has numerous medical publications, presentations and investigations credited to his name. Aside from his clinical expertise as one of “America’s Top Docs” in Allergy/Immunology, Dr. Rabinovitch has an extensive research portfolio. His research has largely centered on the biological and physiological effects of environmental exposures on asthma. He has devoted significant effort on evaluating the association between ambient air pollution, environmental tobacco smoke and bio-aerosols with disease severity among urban children with mild to severe disease and in identifying gene-environment interactions and biomarkers of exposure to air pollution and environmental tobacco smoke in these children. In addition he has investigated and published on the role of biomarkers in predicting individual responses to inhaled corticosteroids and leukotriene modifiers in children with asthma.

Dr. A. Wesley Burks is Executive Dean for the UNC School of Medicine. In this role he is responsible for providing overall academic leadership for the School of Medicine and the UNC Health Care System. He is also the Curnen Distinguished Professor in teh Department of Pediatrics. Dr. Burks’ research interests are in the allergic diseases, particularly adverse reactions to foods. Dr. Burks’ heads a research team whose work centers on the molecular identification of the allergens in specific foods, a better understanding of the mechanism of adverse food reactions, and the development of treatment for food allergy in animal models and in clinical studies. Dr. Burks and his colleagues have several ongoing clinical studies with different types of mucosal immunotherapy. His laboratory funding comes from many sources, including the National Institutes of Health and private foundations. Dr. Burks has been published in many distinguished journals and has authored or coauthored numerous articles, chapters and abstracts. He is a past Chair and member of the NIH Hypersensitivity, Autoimmune, and Immune-mediated Diseases study section and is Past President of the American Academy of Allergy, Asthma and Immunology. Dr. Burks graduated from the University of Central Arkansas and then the University of Arkansas for Medical Sciences. He completed a pediatric residency at the Arkansas Children’s Hospital. Dr. Burks subsequently completed a fellowship in allergy and immunology at Duke University Medical Center. He was previously on the faculty at the University of Arkansas for Medical Sciences and Arkansas Children’s Hospital and Duke University Medical Center.

Dr. Aziz Sheikh is Professor of Primary Care Research and Development and Co-director of Medical Informatics at the Usher Institute of Population Health Sciences and Informatics at The University of Edinburgh, and Honorary Consultant in Pediatric Allergy at the Royal Hospital for Sick Children in Scotland, UK. He is an editorial board member of Medical Care and Health Informatics Journal, Associate Editor of the Journal of the Royal Society of Medicine and the International Journal of Medical Informatics, Editorial Board Member of PLOS Medicine, and Editor-in-Chief of npj: Primary Care Respiratory Medicine. He has advised the Scottish, UK, US and Saudi Governments and the House of Lords on allergy service provision in the UK. Dr. Sheikh is Director of the 14-university Asthma UK Centre for Applied Research (www.aukcar.ac.uk/) and a co-investigator in the Asthma UK Centre in Allergic Mechanisms of Asthma and the Farr Institute. He is Methodology Lead for the European Academy of Allergy and Clinical Immunology (EAACI’s) Guidelines on Food Allergy, Anaphylaxis and Allergen Immunotherapy, and co-leads the section on Diagnosis for the British Thoracic Society/Scottish Intercollegiate Guideline Network (BTS/SIGN) Guideline on Asthma. He is furthermore a serving member of the World Allergy Organization’s (WAO) on Anaphylaxis. He has together with colleagues held research grants in excess of $50m, has over 800 peer-reviewed publications, and over 21,000 citations (Google Scholar) to his work. He is co-editor of Landmark Papers in Allergy (Oxford University Press, 2013) and Middleton’s Allergy Essentials (Elsevier, 2016). Dr. Sheikh has won numerous fellowships and awards, has given keynote and plenary presentations in over 30 countries, and has recently returned to the UK after completing a Harkness Fellowship in Health Policy and Practice based at Brigham and Women’s Hospital/Harvard Medical School in Boston, MA, USA. He holds visiting chairs at the University of Birmingham (UK), Queen Mary’s University of London (UK), Maastricht University (Netherlands) and was recently appointed as Visiting Professor of Medicine at Harvard Medical School. Dr. Sheikh was made an Officer of the Order of the British Empire for Services to Medicine and Health Care by Her Majesty Queen Elizabeth II in 2014.

Corinne Keet, MD, PhD is Associate Professor of Pediatrics in the Division of Pediatric Allergy and Immunology at the Johns Hopkins School of Medicine. She earned her MD from the University of California, San Francisco, and subsequently completed a pediatrics residency, allergy/immunology fellowship and doctorate in Genetic Epidemiology from Johns Hopkins. She joined the faculty at Johns Hopkins in 2010. Dr. Keet is an NIH-funded principal investigator focusing on the epidemiology, prevention and treatment of food allergy. She has published over 40 manuscripts on pediatric allergy. Dr. Keet serves on the editorial boards of JACI: In Practice and the Annals of Allergy, Asthma and Immunology.

Dr. Brian Vickery is a pediatric allergist-immunologist whose clinical and research efforts focus on an improved understanding of food allergies and anaphylaxis and the development of novel therapies. Dr. Vickery completed his undergraduate work at the University of Georgia and then obtained his medical degree from the Medical College of Georgia. He completed pediatric residency at New York-Presbyterian Hospital/Weill Cornell in New York City, and was selected as a chief resident. He then completed his fellowship training in allergy & clinical immunology at Yale University School of Medicine and while there worked on the preclinical development of EMP-123, a novel recombinant protein immunotherapy for peanut allergy. He then joined the faculty at Duke University and the research group of Dr. Wesley Burks, where he worked for four years before moving to UNC as an assistant professor with Dr. Burks in 2012. While at UNC, Dr. Vickery was an NIH-funded researcher and the Director of the UNC Food Allergy Initiative, whose work focused on understanding the biology of food allergy and developing novel therapies. He was first to show the development of sustained unresponsiveness after peanut oral immunotherapy and was the PI of the DEVIL study, the first to focus on early treatment in very young peanut-allergic children. In 2015, he was recruited to Aimmune Therapeutics, where he helps lead the company’s effort to develop standardized, pharmaceutical-grade oral immunotherapy products for FDA approval and licensure. Dr. Vickery remains on the UNC faculty as a clinical assistant professor of pediatrics, where he continues to pursue academic, scholarly, career development, and clinical objectives. He sees children with a variety of allergic disorders at his clinic at the N.C. Children’s Hospital and has been recognized with several awards for clinical care. He has published over 40 papers in leading journals, presented his work at national and international meetings, and won several junior faculty research awards. He serves as a peer reviewer for leading journals and grant agencies; was an invited member of the workgroup that recently revised the Practice Parameter for the Diagnosis and Management of Food Allergy; and is active in the American Academy of Allergy, Asthma, and Immunology, having held leadership positions on several committees.

Dr. Savage is Assistant Professor of Medicine at Harvard Medical School and an allergist within the Division of Rheumatology, Immunology, and Allergy at Brigham and Women’s Hospital (BWH) in Boston as well as the Director of Population Studies in Allergy at BWH and a member of the National Institute of Environmental Health Sciences Center at the Harvard School of Public Health. Her primary research interests focus on the environmental and genetic factors that influence the development of allergy and underlie the recent rise in allergic disease. She is specifically interested in how environmental antimicrobial chemicals may influence the human microbiome and skew the developing immune system towards an allergic phenotype, and her primary disease of interest is food allergy. Dr. Savage spends over 80% of her time conducting clinical, translational, and population-based research supported by funding from the BWH, the NIH, industry, and charitable foundations.

Jonathan Hourihane has been Professor of Paediatrics and Child Health in University College Cork, Ireland since 2005. He graduated from Trinity College Dublin in 1987. He undertook his higher training in Southampton, and London, UK. His primary area of clinical and research interest is in paediatric food allergy and anaphylaxis. He is co-Principal Investigator of the BASELINE, Ireland’s only birth cohort study (www.baselinestudy.net.) and  the INFANT Research Centre in UCC. He was a Board member of RCPI Faculty of Paediatrics 2015-2018. He is a Board member of the National Childrens Research Centre, Ireland and is a member of the NCRC Strategy Committee. He is a founding Board member of the Clemens von Pirquet Foundation, and of the  Irish Food Allergy Network (www.ifan.ie). He is current President of the Irish Association of Allergy and Immunology.